文献速递艾滋病与性传播感染细菌感染、耐药与抗菌药物

超深度测序提高病毒血症抑制的HIV感染ART患者细胞DNA耐药检测

Ultra-deep sequencing improves the detection of drug resistance in cellular DNA from HIV-infected patients on ART with suppressed viraemia.
PubMed 文献 · J Antimicrob Chemother · 2018-01-01

在169例病毒血症抑制且既往血浆检出耐药相关突变的经治HIV患者中,比较HIV DNA的Sanger测序与超深度测序(UDS)检测蛋白酶和逆转录酶基因耐药突变。UDS以20%为阈值时检出率与Sanger测序相似,以1%为阈值时对多个逆转录酶和蛋白酶密码子的检出率显著高于Sanger测序。

要点

  • UDS以1%为阈值可提高细胞HIV DNA中既往血浆耐药突变的检出率。
  • UDS以20%为阈值时与Sanger测序检出耐药突变相似。
  • UDS对逆转录酶和蛋白酶基因测序成功率分别为79%和81%。

核心结论

  • 对病毒血症抑制患者的细胞HIV DNA进行基因型耐药检测应采用灵敏度阈值1%的UDS技术,以提高耐药库的检出。

研究设计与样本

  • 研究纳入169例高度经治且病毒血症抑制的患者(ANRS 138-EASIER试验),对HIV DNA的蛋白酶和逆转录酶基因分别进行Sanger测序和UDS,UDS采用1%和20%两个检测阈值进行比较。

主要发现

  • 患者高度经治(13.6年)。
  • UDS对逆转录酶和蛋白酶基因测序成功分别为133例(79%)和137例(81%)。
  • UDS以20%为阈值时检出耐药相关突变与Sanger测序相似。
  • UDS以1%为阈值时,逆转录酶密码子D67N检出率65.4% vs Sanger测序52.3%、M184V 66.2% vs 52.3%、L210W 48.9% vs 36.4%、T215Y 57.9% vs 42.1%。
  • UDS以1%为阈值时,蛋白酶密码子M46I检出率46% vs Sanger测序26%、I54L 12.4% vs 3.9%、V82A 44.5% vs 29.9%、L90M 57.7% vs 42.5%。

临床怎么用

  • 作者认为,对病毒血症控制良好的患者进行细胞HIV DNA基因型耐药检测时应使用灵敏度阈值1%的UDS技术,以提高耐药库的检出。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Standard genotypic tests performed on HIV DNA from patients on suppressive ART, with previous resistance-associated mutations (RAMs) detected in their plasma, underestimate resistance. We thus compared ultra-deep sequencing (UDS) with bulk sequencing of DNA to detect RAMs previously identified in plasma. METHODS: We sequenced the DNA of 169 highly treatment experienced patients with suppressed viraemia (ANRS 138-EASIER trial). Protease (PR) and reverse transcriptase (RT) genes from HIV DNA were sequenced by bulk sequencing and UDS, comparing 1% and 20% as thresholds of detection for UDS. RESULTS: Patients were highly treatment experienced (13.6 years). UDS of DNA was successful for the RT and PR genes in 133 (79%) and 137 (81%) patients, respectively. The detection of RAMs was similar by bulk sequencing and UDS with a 20% cut-off. However, the detection of RAMs by UDS with a 1% cut-off was significantly higher than that of bulk sequencing for RT codons D67N (65.4% versus 52.3%), M184V (66.2% versus 52.3%), L210W (48.9% versus 36.4%) and T215Y (57.9% versus 42.1%) and PR codons M46I (46% versus 26%), I54L (12.4% versus 3.9%), V82A (44.5% versus 29.9%) and L90M (57.7% versus 42.5%). CONCLUSIONS: Genotypic resistance testing of cellular HIV DNA of well-controlled patients should use UDS technology with a sensitivity threshold of 1% to improve the detection of the resistant reservoir.

来源:J Antimicrob Chemother,查看原文。版权归原作者所有。

引用

  1. Rodriguez C, Nere ML, Demontant V, et al. Ultra-deep sequencing improves the detection of drug resistance in cellular DNA from HIV-infected patients on ART with suppressed viraemia. J Antimicrob Chemother. 2018. PMID: 30137335. doi:10.1093/jac/dky315

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。